Impact of dextrose dose on hypoglycemia development following treatment of hyperkalemia
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: Hyperkalemia is an electrolyte abnormality that may cause ventricular dysrhythmias and cardiac arrest. The presence of hyperkalemia may necessitate prompt treatment via intravenous insulin and dextrose. One notable complication of this therapy is the development of hypoglycemia. Previous trials have examined the impact of altering the insulin dose administered on hypoglycemia development; no trials to date however, have examined the impact of altering the dextrose dose. Methods: This was a multicenter, retrospective, matched cohort study of patients who received intravenous insulin and dextrose for reversal of hyperkalemia. Patients received either 25 g or 50 g of dextrose in addition to 10 units of insulin. Study populations were matched based on preexisting rates of acute kidney injury, end-stage renal disease, and diabetes mellitus. Blood glucose levels were measured at 60 and 240 min following treatment. Results: A total of 240 patients were included in the analysis. At 60 min following treatment, 15.8% of patients who received 25 g of dextrose developed hypoglycemia, as opposed to 8.3% of patients who received 50 g of dextrose ( p = 0.11). Hyperglycemia was more common in patients who received 50 g of dextrose at 60 min posttreatment; however, this difference did not persist at 240 min. Potassium reduction at 60 min did not differ between groups. In patients with a pretreatment blood glucose <110 mg/dl or without diabetes, rates of hypoglycemia were significantly lower when 50 g of dextrose was administered. Conclusion: In the overall patient population, use of 50 g of dextrose instead of 25 g does not reduce hypoglycemia incidence. However, it may be beneficial is select patient populations, such as patients without type 2 diabetes or patients with a baseline blood glucose <110 mg/dl. Administration of 50 g of dextrose did not appear to place patients at significant risk for hyperglycemia however and could be considered during treatment of hyperkalemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Hypoglycemia resulting from severe systemic illness (spontaneous hypoglycemia), rather than insulin-induced hypoglycemia, is associated with increased risk of inpatient mortality and complications.1366–1368”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1368]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
(2005) · Circulation · doi:10.1161/circulationaha.105.166550 · Cited by 1,000
Hypoglycemia and outcome in critically ill patients
Egi, M., Bellomo, R., Stachowski, E., French, C. J., Hart, G. K., Taori, G., Hegarty, C., & Bailey, M. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0394 · Cited by 432
Management of severe hyperkalemia
Weisberg, L. S. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31818f222b · Cited by 268
Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients
Allon, M., & Copkney, C. (1990) · Kidney International · doi:10.1038/ki.1990.284 · Cited by 220
Potassium disorders—clinical spectrum and emergency management
Alfonzo, A. V. M., Isles, C., Geddes, C., & Deighan, C. (2006) · Resuscitation · doi:10.1016/j.resuscitation.2005.11.002 · Cited by 218
Allon, M., & Shanklin, N. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90460-6 · Cited by 159
Management of patients with acute hyperkalemia
Elliott, M., Ronksley, P. E., Clase, C. M., Ahmed, S. B., & Hemmelgarn, B. R. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.100461 · Cited by 116
Brodovicz, K. G., Mehta, V., Zhang, Q., Zhao, C., Davies, M. J., Chen, J., Radican, L., & Engel, S. S. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.754744 · Cited by 112
Kim, H.-J. (1996) · Nephron · doi:10.1159/000188917 · Cited by 83
Zapatero, A., Gómez-Huelgas, R., González, N., Canora, J., Mota, Á. A., Hinojosa, J., Plaza, S., Marco, J., & Barba, R. (2014) · Endocrine Practice · doi:10.4158/ep14006.or · Cited by 76
Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment
Schafers, S., Naunheim, R., Vijayan, A., & Tobin, G. (2012) · Journal of Hospital Medicine · doi:10.1002/jhm.977 · Cited by 70
Hypoglycemia in the treatment of hyperkalemia with insulin in patients with end-stage renal disease
Apel, J., Reutrakul, S., & Baldwin, D. (2014) · Clinical Kidney Journal · doi:10.1093/ckj/sfu026 · Cited by 67
Pierce, D. A., Russell, G., & Pirkle, J. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015607559 · Cited by 48
Weight‐based insulin dosing for acute hyperkalemia results in less hypoglycemia
Wheeler, D. T., Schafers, S. J., Horwedel, T. A., Deal, E. N., & Tobin, G. S. (2016) · Journal of Hospital Medicine · doi:10.1002/jhm.2545 · Cited by 45
Chothia, M., Halperin, M. L., Rensburg, M., Hassan, M. S., & Davids, M. R. (2014) · Nephron Physiology · doi:10.1159/000358836 · Cited by 41
Research works printed but not linked: 1
- 1. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Part 10.1: Life-Threatening Electrolyte Abnormalities. Circulation 2005; 112(24 Suppl.): IV-1–IV-5. [DOI] [PubMed] [Google Scholar]
Cited by
European Resuscitation Council Guidelines 2021: Cardiac arrest in special circumstances
Lott, C., Truhlář, A., Alfonzo, A., Barelli, A., González-Salvado, V., Hinkelbein, J., Nolan, J. P., Paal, P., Perkins, G. D., Thies, K.-C., et al. (2021) · Resuscitation · doi:10.1016/j.resuscitation.2021.02.011 · Cited by 789
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Metadata
- Authors
- Farina, N., & Anderson, C.
- Affiliations
- University of Michigan (US)
- Indiana University Health (US)
- Corresponding author
- Farina, Nicholas
- ORCID
- Farina, Nicholas
- Venue
- Therapeutic Advances in Drug Safety
- Publisher
- SAGE Publications
- Published
- 2018-04-11
- Volume
- 9
- Issue
- 6
- Pages
- 323-329
- ISSN
- 2042-0986 (ISSN-L)
- 2042-0994
- PMC
- PMC5971399
- OpenAlex
- W2797151344
- Cited by
- 30
- References
- 16
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 4 · 2022: 7 · 2021: 7 · 2020: 1 · 2019: 4 · 2018: 2
- FWCI
- 2.64
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Drug Safety (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Potassium and Related Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- hyperkalemia, hypoglycemia, intravenous insulin, hyperglycemia, potassium reduction, diabetes mellitus, acute kidney injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.